Integrating palliative care and symptom relief into primary health care
22
Morphine and other opioids
Morphine, in oral fast-acting
and injectable preparations, is the most clinically important of the essential
palliative care medicines
(44). It must be accessible in the proper form and dose by any patient with terminal
dyspnea or with moderate or severe
pain that is either acute, chronic and associated with malignancy, or
chronic in a patient with a terminal prognosis. Opioids should not be the first-line treatment for chronic
pain outside of cancer, palliative
and end-of-life care, except under special circumstances and with strict
monitoring
(45). Morphine, in both injectable and oral fast-acting formulations, must be accessible by
prescription at any hospital-based clinic. In general, at least oral fast-acting morphine
should be accessible
by prescription at CHCs. All doctors who provide primary care should be adequately trained and legally
empowered to prescribe oral and injectable morphine for inpatients and outpatients in any dose necessary
to provide adequate relief as determined by the patients. Doctors inexperienced in prescribing morphine
can be trained adequately with the curriculum in basic palliative care training
described in this document
or similar curricula. Physicians should also be enabled to prescribe an adequate supply of morphine so
that obtaining refills is feasible for patients or families without requiring unreasonably frequent, expensive
or arduous travel. Whenever clinically possible, oral morphine rather than the
injectable form should be
prescribed. All doctors should be trained to assess and treat opioid side-effects and to avoid injudicious use
of morphine for mild pain or chronic non-malignant pain. In at least one setting (Uganda), specially trained
and supervised nurses are allowed to prescribe and manage morphine analgesia
(41).
Dostları ilə paylaş: